A documentary about menopause has ‘misinformation’ and shouldn’t be used to educate docs, critics say
The film, “The M Factor: Shredding the Silence on Menopause,” is accredited for physicians
Related Articles
Does decaf coffee contain a harmful additive? Advocates want to ban a certain chemical in the brew
Could the FDA ban certain decaf coffees? Advocates want to strip out a chemical in the brew.
The Miseducation of America’s Nurse Practitioners
They don’t merely support doctors—NPs increasingly treat patients independently, including in specialty practices and emergency rooms. When they aren’t well trained, the results can be…
CCRAN’s Early Age Onset Cancer Symposium – OncoDaily
CCRAN’s Early Age Onset Cancer Symposium / cancer, CCRAN, City of Hope, ctDNA, EAOC24, Early Age Onset Cancer, OncoDaily, Oncology, Orange County, Pashtoon Kasi
Cancer of Unknown Primary (CUP)
Learn about effective cancer of unknown primary treatments with the fewest side effects. Customized options: surgery, chemotherapy, radiation therapy, proton therapy.
Multimodal single cell-resolved spatial proteomics reveal pancreatic tumor heterogeneity
Nature Communications – The integration of antibody-guided cell typing and mass spectrometry-based proteomics remains challenging. Here, the authors develop Spatial and Cell-type Proteomics…
Why cancer advocates like me are leaving X
“It’s sad to see the era of Twitter cancer communities end,” writes cancer advocate Janet Freeman-Daily.
State of Lung Cancer | State Data
The American Lung Association’s LUNG FORCE “State of Lung Cancer” report shows how the toll of lung cancer varies by state. Look at the rates…
Large Study Compares Serum Thrombopoietin Levels in Pediatric Patients With Acquired Aplastic Anemia, Immune Thrombocytopenia | ASH Clinical News | American Society of Hematology
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. A large, single-center analysis of pediatric patients with either acquired…
Prostate radiotherapy in the era of intensified systemic treatment of metastatic prostate cancer
For men with low-volume de novo metastatic castration-sensitive prostate cancer, radiotherapy to the prostate is a standard of care option due to the significant improvement…
Pharmalittle: We’re reading about picking an FDA chief, a menopause film controversy, and more
President-elect Donald Trump will likely choose Johns Hopkins surgeon and writer Martin Makary to lead the FDA, sources say
